Marble Harbor Investment Counsel LLC lowered its stake in shares of The Clorox Company (NYSE:CLX – Free Report) by 38.5% during the second quarter, according to the company in its most recent filing with the Securities & Exchange Commission. The institutional investor owned 1,600 shares of the company’s stock after selling 1,000 shares during the period. Marble Harbor Investment Counsel LLC’s holdings in Clorox were worth $218,000 at the end of the most recent quarter.
Several other large investors also recently made changes to their positions in the stock. Kennon Green & Company LLC grew its position in shares of Clorox by 8.2% in the 2nd quarter. Kennon Green & Company LLC now owns 2,046 shares of the company’s stock valued at $279,000 after acquiring an additional 155 shares during the period. Plato Investment Management Ltd increased its position in Clorox by 226.4% during the 2nd quarter. Plato Investment Management Ltd now owns 4,837 shares of the company’s stock worth $660,000 after buying an additional 3,355 shares during the period. Mystic Asset Management Inc. lifted its holdings in shares of Clorox by 2.3% during the second quarter. Mystic Asset Management Inc. now owns 8,483 shares of the company’s stock worth $1,158,000 after buying an additional 190 shares in the last quarter. Wilkins Investment Counsel Inc. boosted its position in shares of Clorox by 3.8% in the second quarter. Wilkins Investment Counsel Inc. now owns 17,134 shares of the company’s stock valued at $2,338,000 after acquiring an additional 620 shares during the period. Finally, J.W. Cole Advisors Inc. grew its stake in shares of Clorox by 9.8% in the second quarter. J.W. Cole Advisors Inc. now owns 2,242 shares of the company’s stock valued at $306,000 after acquiring an additional 200 shares in the last quarter. Institutional investors and hedge funds own 78.53% of the company’s stock.
Analyst Upgrades and Downgrades
Several analysts have weighed in on the stock. DA Davidson reiterated a “neutral” rating and issued a $153.00 price objective on shares of Clorox in a research note on Friday, September 6th. Argus upgraded shares of Clorox to a “hold” rating in a research report on Tuesday, June 4th. JPMorgan Chase & Co. reduced their price target on Clorox from $150.00 to $148.00 and set a “neutral” rating on the stock in a research report on Friday, August 2nd. BNP Paribas upgraded Clorox to a “strong sell” rating in a research note on Friday, September 6th. Finally, Barclays upped their target price on Clorox from $122.00 to $130.00 and gave the company an “underweight” rating in a research report on Monday, August 5th. Six investment analysts have rated the stock with a sell rating and thirteen have given a hold rating to the company. According to data from MarketBeat, the company has an average rating of “Hold” and a consensus target price of $143.50.
Clorox Trading Up 0.8 %
NYSE:CLX opened at $166.27 on Monday. The Clorox Company has a 52 week low of $114.68 and a 52 week high of $167.75. The firm’s fifty day moving average is $146.16 and its 200-day moving average is $143.24. The firm has a market cap of $20.59 billion, a P/E ratio of 86.15, a P/E/G ratio of 3.29 and a beta of 0.40. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03.
Clorox (NYSE:CLX – Get Free Report) last issued its quarterly earnings results on Thursday, August 1st. The company reported $1.82 EPS for the quarter, beating analysts’ consensus estimates of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The business had revenue of $1.90 billion for the quarter, compared to analysts’ expectations of $1.97 billion. Equities analysts expect that The Clorox Company will post 6.63 earnings per share for the current year.
Clorox Increases Dividend
The firm also recently announced a quarterly dividend, which was paid on Friday, August 30th. Shareholders of record on Wednesday, August 14th were issued a $1.22 dividend. This is an increase from Clorox’s previous quarterly dividend of $1.20. This represents a $4.88 dividend on an annualized basis and a yield of 2.93%. The ex-dividend date was Tuesday, August 13th. Clorox’s payout ratio is presently 252.85%.
Insider Buying and Selling at Clorox
In other news, EVP Angela C. Hilt sold 1,733 shares of Clorox stock in a transaction on Friday, September 6th. The shares were sold at an average price of $165.52, for a total value of $286,846.16. Following the completion of the sale, the executive vice president now owns 13,471 shares in the company, valued at approximately $2,229,719.92. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is accessible through this hyperlink. Insiders own 0.51% of the company’s stock.
About Clorox
The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.
See Also
- Five stocks we like better than Clorox
- What is a Low P/E Ratio and What Does it Tell Investors?
- Symbotic’s Double-Bagger Potential as It Hits a Key Inflection
- How to Calculate Options Profits
- High Dividend Yields Make These 2 Shipping Stocks Stand Out
- Investing in Commodities: What Are They? How to Invest in Them
- Can Celsius Stock Rebound? Analysts See 74% Upside Potential
Want to see what other hedge funds are holding CLX? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Clorox Company (NYSE:CLX – Free Report).
Receive News & Ratings for Clorox Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Clorox and related companies with MarketBeat.com's FREE daily email newsletter.